Central nervous system remyelination clinical application of basic neuroscience principles

David J. Miller, Kuni Asakura, Moses Rodriguez

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

Studies in both humans and experimental animals have demonstrated that myelin repair in the CNS is a normal physiological response to myelin damage, similar to tissue injury elsewhere in the body. The unanswered question is why myelin repair is incomplete in multiple sclerosis patients. In this paper we review the morphological characteristics of remyelination, discuss the available animal models of CNS demyelination and their usefulness to identify the molecular, cellular, and morphological events involved in CNS myelin repair, examine the use of immunosuppression, immunoglobulins, protein growth factors, and glial cell transplantation as the primary experimental therapies designed to promote CNS remyelination, and address the potential electrophysiological and clinical benefits of myelin repair in the CNS.

Original languageEnglish (US)
Pages (from-to)331-344
Number of pages14
JournalBrain Pathology
Volume6
Issue number3
DOIs
StatePublished - Jul 1996

    Fingerprint

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neuroscience(all)
  • Clinical Neurology

Cite this